On this page
RBI decision revives Tata Sons listing prospect, putting group stocks in focus
RBI rejected Tata Sons’ bid to remain private, reviving a potential listing. The decision could lift Tata group stocks holding Tata Sons stakes and may force governance, cross-holding and capital-allocation changes affecting Tata’s consumer and retail businesses.
- Tata Chemicals stake in Tata Sons, estimated valueabove ₹17,407 crore
- Tata Chemicals market capitalisation₹15,603 crore
Reported figures
From the report. Source details below
| Tata Chemicals holds about 2.5%, valued above ₹17,407 crore at an estimated | 40% holding-company discount |
|---|---|
| Tata Chemicals market capitalisation was | ₹15,603 crore |
| Tata Sons standalone FY26 revenue was ₹42,366.5 crore and profit was | ₹31,961 crore |
| Four private Tata Sons businesses reported combined losses of | ₹29,924 crore |
| RBI's 2022 directive applied to UL-NBFC/core investment companies with assets of | ₹1 trillion or more |
| Tata Chemicals rose 39% in March 2024; Tata Power rose 15%; Tata Steel and Tata Consumer Products each rose | 6% |
Also in the report
- Tata group companies hold a combined 11.92% stake in Tata Sons
The source
First seen